FDA Inspection
Direct RxDirect Rx – FDA Inspection, Dec 15, 2017
Record Details
This FDA Inspection record concerns Direct Rx, with an inspection on December 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2ec76038-0038-4123-ab24-dcdb74883444
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1034986
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.204Returned drug products identified and held
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Direct Rx
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Atlanta District Office | |
| August 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Direct Rx
- FDA Inspection 1324204 - 2026-06-04
- FDA Inspection 941193 - 2015-08-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.